Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Neo Soma Healthcare vs Renlo Health

Neo Soma Healthcare
Graded #231

Lower grade

vs+13.9
Renlo Health
Graded #41

Higher grade

The verdict

Renlo Health takes it — 79.7/100 to 65.8/100.

Renlo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs whose headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRenlo Health +18
66
84
Dose & formulationEven
72
72
Clinical oversightRenlo Health +16
72
88
Labs & monitoringNeo Soma Healthcare +4
62
58
FulfillmentRenlo Health +33
57
90
Contract termsRenlo Health +35
55
90
Neo Soma Healthcare · left barRenlo Health · right bar

The numbers

MetricNeo Soma HealthcareRenlo Health
WeighScore65.8/10079.7/100
GradeCC+
Scorecard rank#231#41
Semaglutide$199/mo$199/mo, billed monthly at every dose
Tirzepatide$330/mo$269/mo, billed monthly at every dose
CoverageCoverage not publishedNot publicly listed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Neo Soma Healthcare

Graded #231 · C

Strengths

  • LegitScript verification badge present
  • Publishes the FDA compounded-medication disclaimer
  • Pricing shown publicly for all 6 product lines
  • Multi-product platform (GLP-1, sexual health, peptide therapies)
  • First-month discount on semaglutide ($99 entry)

Where it loses points

  • Pharmacy partner not named (503A vs 503B unclear)
  • States served not listed — no per-state availability table
  • No named medical director
  • Standard semaglutide pricing ($199/mo) above the cheapest providers ($150–180/mo)
  • Tirzepatide entry pricing ($330) above the cheapest providers (~$200–250/mo)
Renlo Health

Graded #41 · C+

Strengths

  • The headline is the real month-to-month rate — no prepay division and no commitment behind an asterisk
  • A genuine all-in line: medication, injection supplies, provider evaluation, ongoing care, expedited shipping and unlimited care-team messaging, with no membership or consultation fees
  • Names the prescribing physician, Dr. Sean Arora, MD, and the dispensing pharmacy, VialsRX
  • Same price at every dose with a price-lock badge
  • A four-month money-back guarantee, and cancel anytime with no fee

Where it loses points

  • A struck-through $399 sits beside the price with no published basis — Renlo never says what it was, when it applied or to whom
  • That strikethrough comes from a stylesheet rule rather than a struck-out element, so a markup-level check would report the page clean
  • A comparison table headed "Most GLP-1 providers" quotes $270, $365 and $445 by dose while naming no provider and citing no source
  • A site-wide $50 code means the advertised figure is not the first amount charged
  • No lab protocol is published, and there is no oral or brand route

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard